Recipient Age and Mortality After Liver Transplantation: A Population-based Cohort Study

Abstract

Background

The feasibility of liver transplantation (LT) in elderly recipients remains a topic of debate.

Methods

This cohort study evaluated the impact of recipient's age on LT outcome between January 2007 and May 2016 covered by the Korean National Health Insurance system (n = 9415). Multilevel regression models were used to determine the impact of recipient's age on in-hospital and long-term mortality after LT.

Results

All patients had a first LT, with 2473 transplanted with liver from deceased donors (DD) and 6942 from living donors. The mean age was 52.2 ± 9.0 years. Most LT were performed on patients in their 50s (n = 4290, 45.6%) and 0.9% (n = 84) of the LT was performed on patients older 70 years. The overall in-hospital mortality was 6.3%, and the 3-year mortality was 11.3%. The in-hospital mortality included, 13.5% associated with DDLT and 3.7% involved living donor LT. When compared with that for patients aged 51 to 55 years, the risk of death among recipients older than 70 years was about fourfold higher after adjusting for baseline liver disease (odds ratio, 4.1; 95% confidence interval, 2.21-7.58), and was nearly threefold higher after adjusting for baseline liver disease and perioperative complications (odds ratio, 2.92; 95% confidence interval, 1.37-6.24). Also, the cost of LT increased significantly with age.

Conclusions

The data show that age remains an important risk factor for LT, suggesting that LT should be considered with caution in elderly recipients.

Abstract

The authors examined mortality risk for a large cohort of liver transplant recipients between 2007 and May 2016 covered by the Korean National Health Insurance system (n = 9415). Both costs and mortality were significantly increased in the cohort over 70 years old. Supplemental digital content is available in the text.